ESTRO meets Asia 2024 - Abstract Book

S236

Interdisciplinary – Other

ESTRO meets Asia 2024

1. Brüningk SC, Peacock J, Whelan CJ, Brady-Nicholls R, Yu H-HM, Sahebjam S, et al. Intermittent radiotherapy as alternative treatment for recurrent high grade glioma: a modeling study based on longitudinal tumor measurements. Sci Rep. 2021 Oct 12;11(1):20219.

2. Monaco EA, Grandhi R, Niranjan A, Lunsford LD. The past, present and future of Gamma Knife radiosurgery for brain tumors: the Pittsburgh experience. Expert Rev Neurother. 2012 Apr 9;12(4):437–45.

3. Wang JZ, Li XA, D’Souza WD, Stewart RD. Impact of prolonged fraction delivery times on tumor control: A note of caution for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol. 2003 Oct;57(2):543–52.

4. Shibamoto Y, Ito M, Sugie C, Ogino H, Hara M. Recovery from sublethal damage during intermittent exposures in cultured tumor cells: implications for dose modification in radiosurgery and imrt. Int J Radiat Oncol. 2004 Aug;59(5):1484–90.

5. Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol. 2004 May;59(1):242–9.

6. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;n71.

7. Wang X, Xiong X-P, Lu J, Zhu G-P, He S-Q, Hu C-S, et al. The in vivo study on the radiobiologic effect of prolonged delivery time to tumor control in C57BL mice implanted with Lewis lung cancer. Radiat Oncol. 2011 Dec 12;6(1):4.

8. Jiang L, Xiong X-P, Hu C-S, Ou Z-L, Zhu G-P, Ying , H.-M. In vitro and in vivo studies on radiobiological effects of prolonged fraction delivery time in A549 cells. J Radiat Res. 2013 Mar 1;54(2):230–4.

9. Otsuka S, Shibamoto Y, Iwata H, Murata R, Sugie C, Ito M, et al. Compatibility of the Linear-Quadratic Formalism and Biologically Effective Dose Concept to High-Dose-Per-Fraction Irradiation in a Murine Tumor. Int J Radiat Oncol. 2011 Dec;81(5):1538–43.

10. Sugie C, Shibamoto Y, Ito M, Ogino H, Miyamoto A, Fukaya N, et al. Radiobiologic effect of intermittent radiation exposure in murine tumors. Int J Radiat Oncol. 2006 Feb;64(2):619–24.

11. Tomita N, Shibamoto Y, Ito M, Ogino H, Sugie C, Ayakawa S, et al. Biological effect of intermittent radiation exposure in vivo: Recovery from sublethal damage versus reoxygenation. Radiother Oncol. 2008 Mar;86(3):369– 74.

12. Shibamoto Y, Sasai K, Abe M. The Radiation Response of SCCVII Tumor Cells in C3H/He Mice Varies with the Irradiation Conditions. Radiat Res. 1987 Feb;109(2):352.

13. Ogino H, Shibamoto Y, Sugie C, Ito M. Biological Effects of Intermittent Radiation in Cultured Tumor Cells: Influence of Fraction Number and Dose Per Fraction. J Radiat Res. 2005;46(4):401–6.

14. Jiang L, Xiong X-P, Hu C-S, Ou Z-L, Zhu G-P, Ying H-M. In vitro and in vivo studies on radiobiological effects of prolonged fraction delivery time in A549 cells. J Radiat Res. 2013;54(2):230–4.

15. Mehta SR, Suhag V, Semwal M, Sharma N. Radiotherapy: Basic concepts and recent advances. Med J Armed Forces India. 2010;66(2):158–62.

16. Baskar R, Yap SP, Chua KLM, Itahana K. The diverse and complex roles of radiation on cancer treatment: therapeutic target and genome maintenance. Am J Cancer Res. 2012;2(4):372–82.